Top Markets
Coin of the day
Willow Biosciences Inc. Willow Biosciences Inc.

Willow Biosciences Inc.

WLLW
Rank in Stocks #29406
Founded in 1981 and headquartered in Calgary, Canada, Willow Biosciences Inc.... Founded in 1981 and headquartered in Calgary, Canada, Willow Biosciences Inc. operates as a biotechnology enterprise. The company is dedicated to the creation, manufacturing, and distribution of plant-derived compounds, primarily serving the consumer care, food and beverage, and pharmaceutical industries across Canada. A core part of its product portfolio includes cannabidiol (CBD), cannabigerol (CBG), and various varin cannabinoids, such as cannabigerovarin (CBGV), cannabidivarin (CBDV), and tetrahydrocannabivarin (THCV).
Share Price
$0.1673768
Last synced: 2025-07-17
Market Cap
$21.30M
Change (1 day)
-8.35%
Change (1 year)
0.00%
Country
CA
Trade Willow Biosciences Inc. (WLLW)

Category

P/E ratio for Willow Biosciences Inc. (WLLW)
P/E ratio as of 2026 TTM: 0
According to Willow Biosciences Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Willow Biosciences Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.